Extrapolation of these results to the physiological setting would suggest that, in cancer patients with elevated levels of sFn, monocytes and circulating tumor cells would bind sFn, resulting in the inability of monocytes to adhere to, and kill, tumor cells, resulting in enhanced metastasis. This evidence concerns the gene SFN and neoplasm.